Literature DB >> 17479679

"Occult" neuroendocrine component and rare metastatic pattern in cervical cancer: report of a case and brief review of the literature.

K Rhiem1, M Possover, A Gossmann, K Drebber, P Mallmann, U Ulrich.   

Abstract

Distant metastases in small cell carcinomas of the uterine cervix are rare, and a disseminated manifestation of the disease is uncommon. This is a case report of a 40-year-old woman treated with platin-based radio-chemotherapy for a moderately differentiated squamous cell cervical cancer FIGO Stage IB 1 (with positive paraaortic lymph nodes). One year later she presented with remarkably unusual cutaneous metastases of the left thumb and scalp as the first signs of spread of disease, including kidney, lung and brain metastases. An advanced retrospective immunohistochemical staining of the cervical biopsy discovered a small neuroendocrine component of the carcinoma as the presumably causative factor for the rare metastastic pattern and poor prognosis.

Entities:  

Mesh:

Year:  2007        PMID: 17479679

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  3 in total

1.  Triple malignancy in a single patient including a cervical carcinoma, a basal cell carcinoma of the skin and a neuroendocrine carcinoma from an unknown primary site: A case report and review of the literature.

Authors:  Mohamed Mesmoudi; Saber Boutayeb; Tarik Mahfoud; Rachid Aasab; Nabil Ismaili; Meryem Glaoui; Hassan Errihani
Journal:  J Med Case Rep       Date:  2011-09-19

2.  Brain metastases from cervical cancer reduce longevity independent of overall tumor burden.

Authors:  Ariel Takayanagi; T J Florence; Omid R Hariri; Abigail Armstrong; Pouria Yazdian; Andrew Sumida; Syed A Quadri; Joshua Cohen; Omid S Tehrani
Journal:  Surg Neurol Int       Date:  2019-09-13

3.  Neuroendocrine carcinoma of the cervix: a systematic review of the literature.

Authors:  Clemens B Tempfer; Iris Tischoff; Askin Dogan; Ziad Hilal; Beate Schultheis; Peter Kern; Günther A Rezniczek
Journal:  BMC Cancer       Date:  2018-05-04       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.